Rayan A - Search Results

1

Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption.

Zahran AM, El-Badawy O, Kamel LM, Rayan A, Rezk K, Abdel-Rahim MH. Zahran AM, et al. Among authors: rayan a. Cancer Manag Res. 2021 Aug 3;13:6019-6029. doi: 10.2147/CMAR.S285128. eCollection 2021. Cancer Manag Res. 2021. PMID: 34377021 Free PMC article.

2

Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma.

Rayan A, Abdel Fattah ON, Soliman A, Hasan HA, Zahran AM. Rayan A, et al. J Gastrointest Cancer. 2019 Sep;50(3):519-524. doi: 10.1007/s12029-018-0116-1. J Gastrointest Cancer. 2019. PMID: 29797144 Clinical Trial.

3

Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.

Zahran AM, Mohammed Saleh MF, Sayed MM, Rayan A, Ali AM, Hetta HF. Zahran AM, et al. Among authors: rayan a. Cancer Biomark. 2018;22(3):587-595. doi: 10.3233/CBM-181368. Cancer Biomark. 2018. PMID: 29843224

4

Survival outcomes of CD34⁺CD38^-LSCs and their expression of CD123 in adult AML patients.

Zahran AM, Aly SS, Rayan A, El-Badawy O, Fattah MA, Ali AM, ElBadre HM, Hetta HF. Zahran AM, et al. Among authors: rayan a. Oncotarget. 2018 Sep 25;9(75):34056-34065. doi: 10.18632/oncotarget.26118. eCollection 2018 Sep 25. Oncotarget. 2018. PMID: 30344921 Free PMC article.

5

Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma.

Zahran AM, Abdel-Meguid MM, Ashmawy AM, Rayan A, Elkady A, Elsherbiny NM, Hetta HF. Zahran AM, et al. Among authors: rayan a. Egypt J Immunol. 2018 Jun;25(2):45-52. Egypt J Immunol. 2018. PMID: 30600947

6

Pretreatment detection of circulating and tissue CD133⁺ CD44⁺ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer.

Zahran AM, Rayan A, Fakhry H, Attia AM, Ashmawy AM, Soliman A, Elkady A, Hetta HF. Zahran AM, et al. Among authors: rayan a. Cancer Manag Res. 2019 Feb 7;11:1237-1248. doi: 10.2147/CMAR.S189653. eCollection 2019. Cancer Manag Res. 2019. PMID: 30799951 Free PMC article.

7

Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma.

Zahran AM, Zahran ZAM, El-Badawy O, Abdel-Rahim MH, Ali WAM, Rayan A, Abbas El-Masry M, Abozaid MAA, Hetta HF. Zahran AM, et al. Among authors: rayan a. Immunol Res. 2019 Jun;67(2-3):157-165. doi: 10.1007/s12026-019-09075-x. Immunol Res. 2019. PMID: 31028612

8

Prognostic impact of circulating monocyte subsets in pediatric solid tumors.

Zahran AM, Rayan A, Sayed HAR, Sobhy A, Solimn A, Darwish AM. Zahran AM, et al. Among authors: rayan a. Cancer Biomark. 2019;25(4):371-379. doi: 10.3233/CBM-182212. Cancer Biomark. 2019. PMID: 31322540

9

Monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience.

Zahran AM, Moeen SM, Thabet AF, Rayan A, Abdel-Rahim MH, Mohamed WMY, Hetta HF. Zahran AM, et al. Among authors: rayan a. Leuk Lymphoma. 2020 Jul;61(7):1645-1652. doi: 10.1080/10428194.2020.1728747. Epub 2020 Feb 20. Leuk Lymphoma. 2020. PMID: 32077360

10

Upregulation of CD146 in Pediatric B-Cell Acute Lymphocytic Leukemia and Its Implications on Treatment Outcomes.

Zahran AM, El-Badawy O, Elsayh KI, Mohamed WMY, Riad KF, Abdel-Rahim MH, Rayan A. Zahran AM, et al. Among authors: rayan a. J Immunol Res. 2020 Feb 8;2020:9736159. doi: 10.1155/2020/9736159. eCollection 2020. J Immunol Res. 2020. PMID: 32090132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters